WO2007009143A3 - Verfahren zur herstellung nebivolol - Google Patents

Verfahren zur herstellung nebivolol Download PDF

Info

Publication number
WO2007009143A3
WO2007009143A3 PCT/AT2006/000303 AT2006000303W WO2007009143A3 WO 2007009143 A3 WO2007009143 A3 WO 2007009143A3 AT 2006000303 W AT2006000303 W AT 2006000303W WO 2007009143 A3 WO2007009143 A3 WO 2007009143A3
Authority
WO
WIPO (PCT)
Prior art keywords
producing
separated
nebivolol
formula
producing nebivolol
Prior art date
Application number
PCT/AT2006/000303
Other languages
English (en)
French (fr)
Other versions
WO2007009143A2 (de
Inventor
Christian R Noe
Muhamed Jasic
Hermann Kollmann
Bodo Lachmann
Original Assignee
Pharmacon Forschung & Beratung Gmbh
Christian R Noe
Muhamed Jasic
Hermann Kollmann
Bodo Lachmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2008521739A priority Critical patent/JP2009502750A/ja
Priority to AU2006272420A priority patent/AU2006272420A1/en
Priority to US11/996,370 priority patent/US20080221340A1/en
Priority to BRPI0613610-9A priority patent/BRPI0613610A2/pt
Priority to MX2008000747A priority patent/MX2008000747A/es
Priority to CA002615832A priority patent/CA2615832A1/en
Application filed by Pharmacon Forschung & Beratung Gmbh, Christian R Noe, Muhamed Jasic, Hermann Kollmann, Bodo Lachmann filed Critical Pharmacon Forschung & Beratung Gmbh
Priority to EA200800364A priority patent/EA200800364A1/ru
Priority to EP06760790A priority patent/EP1919888A2/de
Publication of WO2007009143A2 publication Critical patent/WO2007009143A2/de
Publication of WO2007009143A3 publication Critical patent/WO2007009143A3/de
Priority to IL188777A priority patent/IL188777A0/en
Priority to NO20080823A priority patent/NO20080823L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)

Abstract

Gegenstand der Erfindung ist ein Verfahren zur Herstellung des razernischen Wirkstoffes Nebivolol, vorzugsweise als Hydrochlorid gemäß Formel (I) bei welchem diastereomere Cyanhydrine der allgemeinen Formel (II) hergestellt, getrennt und die getrennten Diastereomere nach einer Transformation, vorzugsweise einer teilweisen oder vollen Reduktion der Cyanogruppe oder einer Pinner-Verseifung, miteinander gekoppelt werden.
PCT/AT2006/000303 2005-07-19 2006-07-17 Verfahren zur herstellung nebivolol WO2007009143A2 (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AU2006272420A AU2006272420A1 (en) 2005-07-19 2006-07-17 Method for producing nebivolol
US11/996,370 US20080221340A1 (en) 2005-07-19 2006-07-17 Process for the Production of Nebivolol
BRPI0613610-9A BRPI0613610A2 (pt) 2005-07-19 2006-07-17 processo para preparação de nebivolol
MX2008000747A MX2008000747A (es) 2005-07-19 2006-07-17 Metodo para producir nebivolol.
CA002615832A CA2615832A1 (en) 2005-07-19 2006-07-17 Method for producing nebivolol
JP2008521739A JP2009502750A (ja) 2005-07-19 2006-07-17 ネビボロールの製造方法
EA200800364A EA200800364A1 (ru) 2005-07-19 2006-07-17 Способ получения небиволола
EP06760790A EP1919888A2 (de) 2005-07-19 2006-07-17 Verfahren zur herstellung nebivolol
IL188777A IL188777A0 (en) 2005-07-19 2008-01-15 Method for producing nebivolol
NO20080823A NO20080823L (no) 2005-07-19 2008-02-15 Fremgangsmate for fremstilling av nebivolol

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ATA1214/2005 2005-07-19
AT0121405A AT502220A1 (de) 2005-07-19 2005-07-19 Verfahren zur herstellung von nebivolol

Publications (2)

Publication Number Publication Date
WO2007009143A2 WO2007009143A2 (de) 2007-01-25
WO2007009143A3 true WO2007009143A3 (de) 2007-04-05

Family

ID=37450808

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AT2006/000303 WO2007009143A2 (de) 2005-07-19 2006-07-17 Verfahren zur herstellung nebivolol

Country Status (15)

Country Link
US (1) US20080221340A1 (de)
EP (1) EP1919888A2 (de)
JP (1) JP2009502750A (de)
KR (1) KR20080027368A (de)
CN (1) CN101243062A (de)
AT (1) AT502220A1 (de)
AU (1) AU2006272420A1 (de)
BR (1) BRPI0613610A2 (de)
CA (1) CA2615832A1 (de)
EA (1) EA200800364A1 (de)
IL (1) IL188777A0 (de)
MX (1) MX2008000747A (de)
NO (1) NO20080823L (de)
WO (1) WO2007009143A2 (de)
ZA (1) ZA200800963B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE533752T1 (de) 2008-09-08 2011-12-15 Cadila Pharmaceuticals Ltd Verbesserter herstellungsprozess für nebivolol- hydrocholorid
IT1395354B1 (it) * 2009-07-23 2012-09-14 Zach System Spa Processo di preparazione di nebivololo
DE102010005953A1 (de) 2010-01-27 2011-07-28 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Nebivolol
IT1397962B1 (it) * 2010-02-11 2013-02-04 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
CN102190647A (zh) * 2010-03-12 2011-09-21 浙江海翔药业股份有限公司 一种奈比洛尔的中间体的制备方法
PL3299364T3 (pl) 2015-05-19 2022-02-07 Zhejiang Ausun Pharmaceutical Co., Ltd. Sposób syntezy nebiwololu i jego związek pośredni

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0145067A2 (de) * 1983-12-05 1985-06-19 Janssen Pharmaceutica N.V. 2,2'-Iminobisäthanol-Derivate
CN1683355A (zh) * 2005-03-03 2005-10-19 浙江医药股份有限公司新昌制药厂 Dl－奈必洛尔及其盐酸盐的制备方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0145067A2 (de) * 1983-12-05 1985-06-19 Janssen Pharmaceutica N.V. 2,2'-Iminobisäthanol-Derivate
CN1683355A (zh) * 2005-03-03 2005-10-19 浙江医药股份有限公司新昌制药厂 Dl－奈必洛尔及其盐酸盐的制备方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200616, Derwent World Patents Index; AN 2006-146512, XP002410014 *
JOHANNES, CHARLES W. ET AL: "Zr-Catalyzed Kinetic Resolution of Allylic Ethers and Mo-Catalyzed Chromene Formation in Synthesis. Enantioselective Total Synthesis of the Antihypertensive Agent (S,R,R,R)-Nebivolol", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY , 120(33), 8340-8347 CODEN: JACSAT; ISSN: 0002-7863, 1998, XP002410010 *

Also Published As

Publication number Publication date
JP2009502750A (ja) 2009-01-29
BRPI0613610A2 (pt) 2011-01-18
NO20080823L (no) 2008-04-02
EA200800364A1 (ru) 2008-06-30
CN101243062A (zh) 2008-08-13
AU2006272420A1 (en) 2007-01-25
WO2007009143A2 (de) 2007-01-25
IL188777A0 (en) 2008-08-07
US20080221340A1 (en) 2008-09-11
EP1919888A2 (de) 2008-05-14
ZA200800963B (en) 2009-08-26
AT502220A1 (de) 2007-02-15
KR20080027368A (ko) 2008-03-26
CA2615832A1 (en) 2007-01-25
MX2008000747A (es) 2008-04-14

Similar Documents

Publication Publication Date Title
EP1740156B8 (de) Verfahren zur herstellung einer gegen missbrauch gesicherten, festen darreinchungsform
WO2005037198A3 (en) Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors
EG26976A (en) Amide derivatives, process for production of the same, and method for application thereof as insecticide
WO2006110656A3 (en) Compounds, compositions and methods for the treatment of viral infections and other medical disorders
WO2006023573A3 (en) Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers
WO2011054436A3 (de) Halogenalkyl-substituierte amide als insektizide und akarizide
WO2005042497A3 (en) Benzimidazoles useful as modulators of ion channels
WO2007009143A3 (de) Verfahren zur herstellung nebivolol
EP1770085A4 (de) Diaminderivat, herstellungsverfahren dafür und fungizid mit dem derivat als wirkstoff
WO2005075412A3 (en) Norbornane based cycloaliphatic compounds containing nitrile groups
WO2006081515A3 (en) Duloxetine hydrochloride polymorphs
WO2001095856A3 (en) Urea derivative useful as an anti-cancer agent and process for preparing same
IL164516A0 (en) 2,6-Quimolinyl and 2,6-naphthyl derivatives, processes for preparation them and their uses as vla-4 inhibitors
WO2008021804A3 (en) Therapeutic amides and related compounds
WO2009011305A1 (ja) アミド化合物とその植物病害防除方法
IL180311A0 (en) Process for the preparation of 4,4-difluoro-3-oxobutanoic acid esters
WO2007119120A3 (en) Crystalline polymorphic forms of olopatadine hydrochloride and processes for their preparation
WO2006015716A3 (de) Verfahren zur herstellung der enantiomeren formen von cis-konfigurierten 3-hydroxycyclohexancarbonsäure-derivaten unter verwendung von hydrolasen
WO2007039076A3 (en) Niobium compound
WO2007054969A3 (en) Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride
WO2008023003A8 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
WO2007144699A3 (en) Process for the preparation of alfuzosin
WO2005023808A3 (en) Process for the preparation of renzapride and intermediates thereof
WO2006002073A3 (en) Method for preventing heme-induced lipid peroxidation
WO2006060225A3 (en) Process for asymmetric synthesis of hexahydropyrimido[1,2-a] azepine-2-carboxamides and related compounds

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 186/KOLNP/2008

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 188777

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2008010083

Country of ref document: EG

Ref document number: MX/a/2008/000747

Country of ref document: MX

Ref document number: 12008500116

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: 2615832

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2008521739

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006272420

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 1020087001837

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 565573

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2006760790

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 200680029362.7

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 2006272420

Country of ref document: AU

Date of ref document: 20060717

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2006272420

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 10514

Country of ref document: GE

Ref document number: 200800364

Country of ref document: EA

WWE Wipo information: entry into national phase

Ref document number: 11996370

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2006760790

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0613610

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20080121